Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | – | Sell |
-1,115,025
| Closed | -$101M | – | 271 |
|
|
2025
Q2 | $101M | Buy |
1,115,025
+333,001
| +43% | +$30.4M | 0.29% | 71 |
|
|
2025
Q1 | $73.3M | Buy |
782,024
+259,966
| +50% | +$23.3M | 0.24% | 83 |
|
|
2024
Q4 | $47.5M | Buy |
522,058
+106,913
| +26% | +$10.2M | 0.14% | 142 |
|
|
2024
Q3 | $43.1M | Buy |
415,145
+26,077
| +7% | +$2.66M | 0.13% | 166 |
|
|
2024
Q2 | $37.8M | Sell |
389,068
-35,080
| -8% | -$3.24M | 0.11% | 178 |
|
|
2024
Q1 | $38.2M | Sell |
424,148
-90,094
| -18% | -$7.63M | 0.11% | 179 |
|
|
2023
Q4 | $41M | Buy |
514,242
+60,808
| +13% | +$4.57M | 0.13% | 167 |
|
|
2023
Q3 | $32.2M | Buy |
453,434
+60,252
| +15% | +$4.5M | 0.11% | 188 |
|
|
2023
Q2 | $30.3M | Sell |
393,182
-43,814
| -10% | -$3.39M | 0.1% | 222 |
|
|
2023
Q1 | $32.8M | Sell |
436,996
-267,403
| -38% | -$19.9M | 0.11% | 210 |
|
|
2022
Q4 | $55.5M | Sell |
704,399
-111,613
| -14% | -$8.37M | 0.2% | 125 |
|
|
2022
Q3 | $57.3M | Sell |
816,012
-26,641
| -3% | -$2.09M | 0.23% | 107 |
|
|
2022
Q2 | $67.5M | Sell |
842,653
-639,914
| -43% | -$50M | 0.25% | 98 |
|
|
2022
Q1 | $112M | Sell |
1,482,567
-124,967
| -8% | -$9.9M | 0.32% | 75 |
|
|
2021
Q4 | $137M | Buy |
1,607,534
+764,728
| +91% | +$59.7M | 0.35% | 65 |
|
|
2021
Q3 | $63.7M | Sell |
842,806
-718,884
| -46% | -$57.1M | 0.18% | 143 |
|
|
2021
Q2 | $127M | Buy |
1,561,690
+30,072
| +2% | +$2.46M | 0.36% | 60 |
|
|
2021
Q1 | $121M | Buy |
1,531,618
+28,894
| +2% | +$2.26M | 0.37% | 60 |
|
|
2020
Q4 | $128M | Buy |
1,502,724
+167,673
| +13% | +$13.9M | 0.4% | 50 |
|
|
2020
Q3 | $103M | Buy |
1,335,051
+272,298
| +26% | +$20.8M | 0.37% | 56 |
|
|
2020
Q2 | $77.9M | Buy |
1,062,753
+294,336
| +38% | +$20.9M | 0.31% | 76 |
|
|
2020
Q1 | $51M | Buy |
768,417
+188,515
| +33% | +$13.3M | 0.25% | 98 |
|
|
2019
Q4 | $39.9M | Sell |
579,902
-107,545
| -16% | -$7.33M | 0.16% | 157 |
|
|
2019
Q3 | $50.5M | Sell |
687,447
-433,685
| -39% | -$31.5M | 0.2% | 129 |
|
|
2019
Q2 | $80.4M | Sell |
1,121,132
-575,586
| -34% | -$40.9M | 0.31% | 76 |
|
|
2019
Q1 | $116M | Buy |
1,696,718
+222,907
| +15% | +$14.4M | 0.45% | 39 |
|
|
2018
Q4 | $87.7M | Buy |
1,473,811
+647,703
| +78% | +$40.5M | 0.38% | 61 |
|
|
2018
Q3 | $55.3M | Buy |
826,108
+356,290
| +76% | +$23.7M | 0.2% | 139 |
|
|
2018
Q2 | $30.4M | Buy |
469,818
+70,689
| +18% | +$4.62M | 0.12% | 220 |
|
|
2018
Q1 | $28.6M | Sell |
399,129
-296,991
| -43% | -$21.4M | 0.11% | 218 |
|
|
2017
Q4 | $52.5M | Sell |
696,120
-123,578
| -15% | -$9.02M | 0.21% | 144 |
|
|
2017
Q3 | $59.7M | Sell |
819,698
-13,603
| -2% | -$980K | 0.26% | 106 |
|
|
2017
Q2 | $61.8M | Sell |
833,301
-54,728
| -6% | -$4.06M | 0.28% | 92 |
|
|
2017
Q1 | $65M | Buy |
888,029
+3,594
| +0.4% | +$252K | 0.29% | 88 |
|
|
2016
Q4 | $57.9M | Sell |
884,435
-6,216
| -0.7% | -$426K | 0.27% | 107 |
|
|
2016
Q3 | $66M | Buy |
890,651
+15,556
| +2% | +$1.15M | 0.29% | 96 |
|
|
2016
Q2 | $64.1M | Sell |
875,095
-6,767
| -0.8% | -$482K | 0.29% | 96 |
|
|
2016
Q1 | $62.3M | Sell |
881,862
-18,626
| -2% | -$1.24M | 0.28% | 97 |
|
|
2015
Q4 | $60M | Buy |
900,488
+58,159
| +7% | +$3.87M | 0.26% | 109 |
|
|
2015
Q3 | $53.5M | Buy |
842,329
+28,739
| +4% | +$1.88M | 0.22% | 126 |
|
|
2015
Q2 | $53.2M | Buy |
813,590
+175,218
| +27% | +$11.9M | 0.21% | 138 |
|
|
2015
Q1 | $44.3M | Buy |
638,372
+18,947
| +3% | +$1.31M | 0.18% | 150 |
|
|
2014
Q4 | $42.9M | Buy |
619,425
+25,006
| +4% | +$1.69M | 0.17% | 159 |
|
|
2014
Q3 | $38.8M | Buy |
594,419
+2,293
| +0.4% | +$151K | 0.17% | 170 |
|
|
2014
Q2 | $40.4M | Buy |
592,126
+188,227
| +47% | +$12.6M | 0.17% | 168 |
|
|
2014
Q1 | $26.2M | Buy |
403,899
+49,092
| +14% | +$3.09M | 0.11% | 208 |
|
|
2013
Q4 | $23.1M | Buy |
354,807
+33,406
| +10% | +$2.14M | 0.1% | 221 |
|
|
2013
Q3 | $19.1M | Buy |
321,401
+2,329
| +0.7% | +$138K | 0.09% | 238 |
|
|
2013
Q2 | $18.3M | Buy |
+319,072
| New | +$18.9M | 0.1% | 226 |
|
Other funds holding CL
Axa's CL Position: Q3 2025 in Review
Axa sold out of Colgate-Palmolive (CL) in Q3 2025, closing a stake of 1,115,025 shares — an estimated $101M sold.
Axa first reported a position in CL in Q2 2013 and held it in 49 quarters. The position peaked at $137M in Q4 2021. 1,843 funds tracked by Wall St. Rank hold CL as of Q3 2025.
- Axa reported no remaining Colgate-Palmolive position as of Q3 2025 after selling out during the quarter.
- Axa sold 1,115,025 Colgate-Palmolive shares in Q3 2025, an estimated $101M.
- Axa first reported a position in Colgate-Palmolive in Q2 2013 and held it in 49 quarters.
- Axa's Colgate-Palmolive position peaked at $137M in Q4 2021.
- 1,843 funds tracked by Wall St. Rank held Colgate-Palmolive as of Q3 2025.
Based on Axa's 13F filing for Q3 2025, filed 14 Nov 2025.